A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes

NCT04585776 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: LY900014
DRUG: Insulin Degludec

Sponsor

Eli Lilly and Company